Podcast Episodes
Back to Search
JAK Inhibitors for New Indications
Episode 1178
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.
1 year, 11 months ago
Transition from Psoriasis to PsA: Can we Prevent It?
Episode 1177
Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria.
1 year, 11 months ago
EULAR 2024 Daily Recap - Days 1 & 2
Episode 1176
Moderated by Dr. Jack Cush and featuring Dr. Yuz Yusof and Dr. Mrinalini Dey
1 year, 11 months ago
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Episode 1175
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
1 year, 11 months ago
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Episode 1174
Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.
1 year, 11 months ago
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Episode 1173
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria:
OP0195 Sonelokimab IL 17 A/F n…
1 year, 11 months ago
Voclosporin and Steroids in Lupus Nephritis
Episode 1172
Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria.
1 year, 11 months ago
3 Big Lupus Themes from EULAR 2024
Episode 1171
Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria.
1 year, 11 months ago
Does B Cell Depletion Matter?
Episode 1170
Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria.
1 year, 11 months ago
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Episode 1169
Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria.
OP0046 Effect on SI joint structural lesions wit…
1 year, 11 months ago